U.S. equities experienced their worst week of losses since the financial crisis as coronavirus fears took hold. The news on the coronavirus seemed to be negative from the beginning of the week to the end, with the chances of a self-fulfilling vicious cycle of fear being reinforced almost constantly. The restrictions on travel and uptick in worldwide cases added to fears about the impact of the virus on global economic output and the effectiveness of government and monetary policy efforts to combat it.
U.S. interest rates fell to all-time lows as fears about the weakening economy and the potential for central bank action pushed the 10-year Treasury yield to as low as 1.03%. To put that level in perspective, the 10-year yield started the year at 1.92%. The fall in Treasury yield has caught the market offsides and the buying of Treasuries as a result of risk-parity trading and other forced buyers of interest rates has been insatiable. The expectation is building for a 50 basis-point interest rate cut by the Federal Reserve, either preemptively or at the March meeting. In advance, LIBOR saw its biggest decline in yield since 2008.
I do think the equity market was overbought and complacent to the impact the virus was having in China entering last week. Whether or not this is a good buying opportunity will have a lot to do with the measures the U.S. and foreign governments impose to help control the spread of the virus. Given the uncertainty of the next several weeks, I think picking a specific bottom will be difficult. My advice is to look for value in sectors or names that are seeing price declines in sympathy with the overall market, but have strong balance sheets and business fundamentals.
This blog post is for informational use only. The views expressed are those of the author(s), and do not necessarily reflect the views of Penn Mutual Asset Management. This material is not intended to be relied upon as a forecast, research or investment advice, and it is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy.
Any statements about financial and company performance of The Penn Mutual Life Insurance Company or its insurance subsidiaries (each, “Client”) made by the author is provided with a written consent from the Client. Penn Mutual Asset Management is a wholly owned subsidiary of The Penn Mutual Life Insurance Company.
Opinions and statements of financial market trends that are based on current market conditions constitute judgment of the author and are subject to change without notice. The information and opinions contained in this material are derived from sources deemed to be reliable but should not be assumed to be accurate or complete. Statements that reflect projections or expectations of future financial or economic performance of the markets may be considered forward-looking statements. Actual results may differ significantly. Any forecasts contained in this material are based on various estimates and assumptions, and there can be no assurance that such estimates or assumptions will prove accurate.
Investing involves risk, including possible loss of principal. Past performance is no guarantee of future results. All information referenced in preparation of this material has been obtained from sources believed to be reliable, but accuracy and completeness are not guaranteed. There is no representation or warranty as to the accuracy of the information and Penn Mutual Asset Management shall have no liability for decisions based upon such information.
High-Yield bonds are subject to greater fluctuations in value and risk of loss of income and principal. Investing in higher yielding, lower rated corporate bonds have a greater risk of price fluctuations and loss of principal and income than U.S. Treasury bonds and bills. Government securities offer a higher degree of safety and are guaranteed as to the timely payment of principal and interest if held to maturity.
All trademarks are the property of their respective owners. This material may not be reproduced in whole or in part in any form, or referred to in any other publication, without express written permission.